| 1 | sudden | 2,852 |
| 2 | nonsteroidal | 1,147 |
| 3 | non-steroidal | 791 |
| 4 | out-of-hospital | 383 |
| 5 | non-steroid | 60 |
| 6 | anglo-scandinavian | 44 |
| 7 | nonsteroid | 34 |
| 8 | nonarrhythmic | 27 |
| 9 | noninsulin | 23 |
| 10 | bone-anchored | 21 |
| 11 | nonsudden | 16 |
| 12 | non-sudden | 15 |
| 13 | non-arrhythmic | 13 |
| 14 | fas-associated | 11 |
| 15 | surreptitious | 10 |
| 16 | melanoma-related | 8 |
| 17 | non-trauma | 8 |
| 18 | progression-related | 8 |
| 19 | pump-failure | 8 |
| 20 | mediator-specific | 6 |
| 21 | pre-stent | 6 |
| 22 | pro-and | 6 |
| 23 | beam-hardening | 5 |
| 24 | physician-assisted | 5 |
| 25 | thromboembolism-related | 5 |
| 26 | aac-induced | 4 |
| 27 | centrotemporal | 4 |
| 28 | microtubule-targeting | 4 |
| 29 | non-heritable | 4 |
| 30 | pc-related | 4 |
| 31 | pchm-derived | 4 |
| 32 | tissue-tracking | 4 |
| 33 | 10-kg | 3 |
| 34 | hemilateral | 3 |
| 35 | manikin-simulated | 3 |
| 36 | mechanism-mediated | 3 |
| 37 | non-her2-gene | 3 |
| 38 | percentile-based | 3 |
| 39 | post-first-line | 3 |
| 40 | prebiotic-containing | 3 |
| 41 | preshunt | 3 |
| 42 | sub-obstructive | 3 |
| 43 | ttr-related | 3 |
| 44 | 10850 | 2 |
| 45 | 99mtc-rbc | 2 |
| 46 | apoptotic-cell | 2 |
| 47 | asphyxia-induced | 2 |
| 48 | aspirin/nonsteroidal | 2 |
| 49 | burn-generated | 2 |
| 50 | cardiovascular/unexplained | 2 |
| 51 | cme-induced | 2 |
| 52 | cps-induced | 2 |
| 53 | cytokine-suppressive | 2 |
| 54 | dobutamine-stimulated | 2 |
| 55 | gastric-cancer-related | 2 |
| 56 | glutathiolated | 2 |
| 57 | gos-containing | 2 |
| 58 | intraoperative/postoperative | 2 |
| 59 | kcn-induced | 2 |
| 60 | non-steriodal | 2 |
| 61 | non-terminating | 2 |
| 62 | plr1-δ | 2 |
| 63 | pressure-sensor | 2 |
| 64 | saponin-permeabilized | 2 |
| 65 | sht-related | 2 |
| 66 | sic-like | 2 |
| 67 | sympathetic-linked | 2 |
| 68 | tab-induced | 2 |
| 69 | treatment-exacerbated | 2 |
| 70 | vinorelbine-related | 2 |
| 71 | 'autophagic | 1 |
| 72 | 'exp | 1 |
| 73 | 'lingering | 1 |
| 74 | -200±30 | 1 |
| 75 | 1,192,082 | 1 |
| 76 | 1/programmed | 1 |
| 77 | 1extra | 1 |
| 78 | 33-week-gestation | 1 |
| 79 | 5.5-month-old | 1 |
| 80 | 52-105 | 1 |
| 81 | 5=brain | 1 |
| 82 | 6,390 | 1 |
| 83 | 6.3-t | 1 |
| 84 | 6.5-20.5 | 1 |
| 85 | 6.6±0.7 | 1 |
| 86 | 7-hydroxy-3,4-dihydrocadalin-induced | 1 |
| 87 | abt-induced | 1 |
| 88 | accidental/bad | 1 |
| 89 | acellular/cellular | 1 |
| 90 | acheulian | 1 |
| 91 | advoided | 1 |
| 92 | all-stroke | 1 |
| 93 | aminoquinoline-5,8-dione | 1 |
| 94 | analgesia/paracetamol/non-steroidal | 1 |
| 95 | anthracycline-associated | 1 |
| 96 | anti-acne/ | 1 |
| 97 | antidepressant/ | 1 |
| 98 | antiprogrammed | 1 |
| 99 | antireticular | 1 |
| 100 | anxioselective | 1 |
| 101 | apoptosis-based | 1 |
| 102 | apoptosis-cell | 1 |
| 103 | arf-associated | 1 |
| 104 | arrhythmic/sudden | 1 |
| 105 | b2-selective | 1 |
| 106 | bak/bax | 1 |
| 107 | basal/standard | 1 |
| 108 | bcl-xl-inhibitable | 1 |
| 109 | bd-associated | 1 |
| 110 | best-value | 1 |
| 111 | beyond-bp-lowering | 1 |
| 112 | bivariate/multivariate | 1 |
| 113 | bridging-exercise | 1 |
| 114 | cardiomuscular | 1 |
| 115 | cardiovascolar | 1 |
| 116 | cardiovascular/vascular | 1 |
| 117 | cbt/cc | 1 |
| 118 | ccr2-mediated | 1 |
| 119 | cd107-expressing | 1 |
| 120 | centro-temporal | 1 |
| 121 | cerl2-associated | 1 |
| 122 | chemoradiotherapy-related | 1 |
| 123 | continuously-superfused | 1 |
| 124 | controls-mean | 1 |
| 125 | cr-mediated | 1 |
| 126 | cytokine-suppressing | 1 |
| 127 | dca+nutlin-3 | 1 |
| 128 | death/mi/stroke/non-cabg | 1 |
| 129 | deguelin-mediated | 1 |
| 130 | dft-caused | 1 |
| 131 | diandric | 1 |
| 132 | dispatcher-identified | 1 |
| 133 | dmba-specific | 1 |
| 134 | dmc-mediated | 1 |
| 135 | dmd-associated | 1 |
| 136 | double-polarization | 1 |
| 137 | double-spin | 1 |
| 138 | doxorubicin-dose-related | 1 |
| 139 | doxorubicin-mediated | 1 |
| 140 | edbd-based | 1 |
| 141 | endokeratoplasty | 1 |
| 142 | enzastaurin-related | 1 |
| 143 | events-cardiac | 1 |
| 144 | every-6-month | 1 |
| 145 | fast-activating | 1 |
| 146 | fetal/embryonic | 1 |
| 147 | fingerprint-associated | 1 |
| 148 | five-bed | 1 |
| 149 | fura-2am-loaded | 1 |
| 150 | goserelin/ovariectomy | 1 |
| 151 | grb-mediated | 1 |
| 152 | hd-pbsct-related | 1 |
| 153 | ho-1-induced | 1 |
| 154 | hplc-dad-ms. | 1 |
| 155 | hydrophilic/hydrophobic | 1 |
| 156 | hypomagnesemic-related | 1 |
| 157 | i-r-induced | 1 |
| 158 | icd-lead | 1 |
| 159 | icg-derived | 1 |
| 160 | iim-capable | 1 |
| 161 | imidazo-pyridine | 1 |
| 162 | infection/or | 1 |
| 163 | insights-both | 1 |
| 164 | intra-/postoperative | 1 |
| 165 | ish.perioperative | 1 |
| 166 | krg-mediated | 1 |
| 167 | left-and | 1 |
| 168 | lymphoma-related | 1 |
| 169 | macrolide-mediated | 1 |
| 170 | macrophage-dependent | 1 |
| 171 | med-food | 1 |
| 172 | mln4924-mediated | 1 |
| 173 | mlt-induced | 1 |
| 174 | multiple-cause-coded | 1 |
| 175 | necroptotic | 1 |
| 176 | nectariana | 1 |
| 177 | nh2-containing | 1 |
| 178 | nk92-mi | 1 |
| 179 | non-lead-related | 1 |
| 180 | non-nonsteroidal | 1 |
| 181 | non-rejecting | 1 |
| 182 | nonsteriodal | 1 |
| 183 | nontreatable | 1 |
| 184 | onassis | 1 |
| 185 | ovarian-cancer | 1 |
| 186 | ovary-type | 1 |
| 187 | p416 | 1 |
| 188 | parasympathetic-linked | 1 |
| 189 | penk-adjusted | 1 |
| 190 | perforationlike | 1 |
| 191 | perfusion™ | 1 |
| 192 | perioerative | 1 |
| 193 | physician-designated | 1 |
| 194 | post-beta-blockade | 1 |
| 195 | post-ir-associated | 1 |
| 196 | post-preservative | 1 |
| 197 | post-septostomy | 1 |
| 198 | post-spartum | 1 |
| 199 | pre-angioplasty | 1 |
| 200 | pre-brain | 1 |
| 201 | preload-dependant | 1 |
| 202 | prognosis-validated | 1 |
| 203 | psycho-vegetative | 1 |
| 204 | quad-frequency | 1 |
| 205 | rats’ | 1 |
| 206 | regression-to-the-mean | 1 |
| 207 | religious-based | 1 |
| 208 | resistance-because | 1 |
| 209 | response-specific | 1 |
| 210 | restriction/fetal | 1 |
| 211 | resveratrol-inspired | 1 |
| 212 | riskfor | 1 |
| 213 | rutaceous | 1 |
| 214 | rv-dilation-associated | 1 |
| 215 | safe-zone | 1 |
| 216 | scn5a-encoded | 1 |
| 217 | score-identified | 1 |
| 218 | semaphorin-based | 1 |
| 219 | sensorineuronal | 1 |
| 220 | serosfuse | 1 |
| 221 | shoseiryuto-mediated | 1 |
| 222 | shs-induced | 1 |
| 223 | skill-specific | 1 |
| 224 | smear-defined | 1 |
| 225 | smoking/injury | 1 |
| 226 | studienhospital | 1 |
| 227 | supra/infraclaviculary | 1 |
| 228 | symbiotic-supplemented | 1 |
| 229 | sytemic | 1 |
| 230 | tacrine-based | 1 |
| 231 | tak1-dependent | 1 |
| 232 | tcc-based | 1 |
| 233 | tenuiflora-like | 1 |
| 234 | tetrahydroquinoline-derived | 1 |
| 235 | thermodilution-based | 1 |
| 236 | tissue-obscuring | 1 |
| 237 | tnfr1-mediated | 1 |
| 238 | tnfr1-tnfr-associated | 1 |
| 239 | tradd-fas-associated | 1 |
| 240 | trandolopril | 1 |
| 241 | treatment-attributed | 1 |
| 242 | triptan-induced | 1 |
| 243 | vaccine-generated | 1 |
| 244 | val-mediated | 1 |
| 245 | vegfr-targeting | 1 |
| 246 | ventricular-arrhythmia-induced | 1 |
| 247 | vk4s | 1 |
| 248 | world-isolating | 1 |
| 249 | yokukansan-induced | 1 |
| 250 | β-ar-induced | 1 |
| 1 | 'autophagic | 1 |
| 2 | 'exp | 1 |
| 3 | 'lingering | 1 |
| 4 | -200±30 | 1 |
| 5 | 1,192,082 | 1 |
| 6 | 1/programmed | 1 |
| 7 | 10-kg | 3 |
| 8 | 10850 | 2 |
| 9 | 1extra | 1 |
| 10 | 33-week-gestation | 1 |
| 11 | 5.5-month-old | 1 |
| 12 | 52-105 | 1 |
| 13 | 5=brain | 1 |
| 14 | 6,390 | 1 |
| 15 | 6.3-t | 1 |
| 16 | 6.5-20.5 | 1 |
| 17 | 6.6±0.7 | 1 |
| 18 | 7-hydroxy-3,4-dihydrocadalin-induced | 1 |
| 19 | 99mtc-rbc | 2 |
| 20 | aac-induced | 4 |
| 21 | abt-induced | 1 |
| 22 | accidental/bad | 1 |
| 23 | acellular/cellular | 1 |
| 24 | acheulian | 1 |
| 25 | advoided | 1 |
| 26 | all-stroke | 1 |
| 27 | aminoquinoline-5,8-dione | 1 |
| 28 | analgesia/paracetamol/non-steroidal | 1 |
| 29 | anglo-scandinavian | 44 |
| 30 | anthracycline-associated | 1 |
| 31 | anti-acne/ | 1 |
| 32 | antidepressant/ | 1 |
| 33 | antiprogrammed | 1 |
| 34 | antireticular | 1 |
| 35 | anxioselective | 1 |
| 36 | apoptosis-based | 1 |
| 37 | apoptosis-cell | 1 |
| 38 | apoptotic-cell | 2 |
| 39 | arf-associated | 1 |
| 40 | arrhythmic/sudden | 1 |
| 41 | asphyxia-induced | 2 |
| 42 | aspirin/nonsteroidal | 2 |
| 43 | b2-selective | 1 |
| 44 | bak/bax | 1 |
| 45 | basal/standard | 1 |
| 46 | bcl-xl-inhibitable | 1 |
| 47 | bd-associated | 1 |
| 48 | beam-hardening | 5 |
| 49 | best-value | 1 |
| 50 | beyond-bp-lowering | 1 |
| 51 | bivariate/multivariate | 1 |
| 52 | bone-anchored | 21 |
| 53 | bridging-exercise | 1 |
| 54 | burn-generated | 2 |
| 55 | cardiomuscular | 1 |
| 56 | cardiovascolar | 1 |
| 57 | cardiovascular/unexplained | 2 |
| 58 | cardiovascular/vascular | 1 |
| 59 | cbt/cc | 1 |
| 60 | ccr2-mediated | 1 |
| 61 | cd107-expressing | 1 |
| 62 | centro-temporal | 1 |
| 63 | centrotemporal | 4 |
| 64 | cerl2-associated | 1 |
| 65 | chemoradiotherapy-related | 1 |
| 66 | cme-induced | 2 |
| 67 | continuously-superfused | 1 |
| 68 | controls-mean | 1 |
| 69 | cps-induced | 2 |
| 70 | cr-mediated | 1 |
| 71 | cytokine-suppressing | 1 |
| 72 | cytokine-suppressive | 2 |
| 73 | dca+nutlin-3 | 1 |
| 74 | death/mi/stroke/non-cabg | 1 |
| 75 | deguelin-mediated | 1 |
| 76 | dft-caused | 1 |
| 77 | diandric | 1 |
| 78 | dispatcher-identified | 1 |
| 79 | dmba-specific | 1 |
| 80 | dmc-mediated | 1 |
| 81 | dmd-associated | 1 |
| 82 | dobutamine-stimulated | 2 |
| 83 | double-polarization | 1 |
| 84 | double-spin | 1 |
| 85 | doxorubicin-dose-related | 1 |
| 86 | doxorubicin-mediated | 1 |
| 87 | edbd-based | 1 |
| 88 | endokeratoplasty | 1 |
| 89 | enzastaurin-related | 1 |
| 90 | events-cardiac | 1 |
| 91 | every-6-month | 1 |
| 92 | fas-associated | 11 |
| 93 | fast-activating | 1 |
| 94 | fetal/embryonic | 1 |
| 95 | fingerprint-associated | 1 |
| 96 | five-bed | 1 |
| 97 | fura-2am-loaded | 1 |
| 98 | gastric-cancer-related | 2 |
| 99 | glutathiolated | 2 |
| 100 | gos-containing | 2 |
| 101 | goserelin/ovariectomy | 1 |
| 102 | grb-mediated | 1 |
| 103 | hd-pbsct-related | 1 |
| 104 | hemilateral | 3 |
| 105 | ho-1-induced | 1 |
| 106 | hplc-dad-ms. | 1 |
| 107 | hydrophilic/hydrophobic | 1 |
| 108 | hypomagnesemic-related | 1 |
| 109 | i-r-induced | 1 |
| 110 | icd-lead | 1 |
| 111 | icg-derived | 1 |
| 112 | iim-capable | 1 |
| 113 | imidazo-pyridine | 1 |
| 114 | infection/or | 1 |
| 115 | insights-both | 1 |
| 116 | intra-/postoperative | 1 |
| 117 | intraoperative/postoperative | 2 |
| 118 | ish.perioperative | 1 |
| 119 | kcn-induced | 2 |
| 120 | krg-mediated | 1 |
| 121 | left-and | 1 |
| 122 | lymphoma-related | 1 |
| 123 | macrolide-mediated | 1 |
| 124 | macrophage-dependent | 1 |
| 125 | manikin-simulated | 3 |
| 126 | mechanism-mediated | 3 |
| 127 | med-food | 1 |
| 128 | mediator-specific | 6 |
| 129 | melanoma-related | 8 |
| 130 | microtubule-targeting | 4 |
| 131 | mln4924-mediated | 1 |
| 132 | mlt-induced | 1 |
| 133 | multiple-cause-coded | 1 |
| 134 | necroptotic | 1 |
| 135 | nectariana | 1 |
| 136 | nh2-containing | 1 |
| 137 | nk92-mi | 1 |
| 138 | non-arrhythmic | 13 |
| 139 | non-her2-gene | 3 |
| 140 | non-heritable | 4 |
| 141 | non-lead-related | 1 |
| 142 | non-nonsteroidal | 1 |
| 143 | non-rejecting | 1 |
| 144 | non-steriodal | 2 |
| 145 | non-steroid | 60 |
| 146 | non-steroidal | 791 |
| 147 | non-sudden | 15 |
| 148 | non-terminating | 2 |
| 149 | non-trauma | 8 |
| 150 | nonarrhythmic | 27 |
| 151 | noninsulin | 23 |
| 152 | nonsteriodal | 1 |
| 153 | nonsteroid | 34 |
| 154 | nonsteroidal | 1,147 |
| 155 | nonsudden | 16 |
| 156 | nontreatable | 1 |
| 157 | onassis | 1 |
| 158 | out-of-hospital | 383 |
| 159 | ovarian-cancer | 1 |
| 160 | ovary-type | 1 |
| 161 | p416 | 1 |
| 162 | parasympathetic-linked | 1 |
| 163 | pc-related | 4 |
| 164 | pchm-derived | 4 |
| 165 | penk-adjusted | 1 |
| 166 | percentile-based | 3 |
| 167 | perforationlike | 1 |
| 168 | perfusion™ | 1 |
| 169 | perioerative | 1 |
| 170 | physician-assisted | 5 |
| 171 | physician-designated | 1 |
| 172 | plr1-δ | 2 |
| 173 | post-beta-blockade | 1 |
| 174 | post-first-line | 3 |
| 175 | post-ir-associated | 1 |
| 176 | post-preservative | 1 |
| 177 | post-septostomy | 1 |
| 178 | post-spartum | 1 |
| 179 | pre-angioplasty | 1 |
| 180 | pre-brain | 1 |
| 181 | pre-stent | 6 |
| 182 | prebiotic-containing | 3 |
| 183 | preload-dependant | 1 |
| 184 | preshunt | 3 |
| 185 | pressure-sensor | 2 |
| 186 | pro-and | 6 |
| 187 | prognosis-validated | 1 |
| 188 | progression-related | 8 |
| 189 | psycho-vegetative | 1 |
| 190 | pump-failure | 8 |
| 191 | quad-frequency | 1 |
| 192 | rats’ | 1 |
| 193 | regression-to-the-mean | 1 |
| 194 | religious-based | 1 |
| 195 | resistance-because | 1 |
| 196 | response-specific | 1 |
| 197 | restriction/fetal | 1 |
| 198 | resveratrol-inspired | 1 |
| 199 | riskfor | 1 |
| 200 | rutaceous | 1 |
| 201 | rv-dilation-associated | 1 |
| 202 | safe-zone | 1 |
| 203 | saponin-permeabilized | 2 |
| 204 | scn5a-encoded | 1 |
| 205 | score-identified | 1 |
| 206 | semaphorin-based | 1 |
| 207 | sensorineuronal | 1 |
| 208 | serosfuse | 1 |
| 209 | shoseiryuto-mediated | 1 |
| 210 | shs-induced | 1 |
| 211 | sht-related | 2 |
| 212 | sic-like | 2 |
| 213 | skill-specific | 1 |
| 214 | smear-defined | 1 |
| 215 | smoking/injury | 1 |
| 216 | studienhospital | 1 |
| 217 | sub-obstructive | 3 |
| 218 | sudden | 2,852 |
| 219 | supra/infraclaviculary | 1 |
| 220 | surreptitious | 10 |
| 221 | symbiotic-supplemented | 1 |
| 222 | sympathetic-linked | 2 |
| 223 | sytemic | 1 |
| 224 | tab-induced | 2 |
| 225 | tacrine-based | 1 |
| 226 | tak1-dependent | 1 |
| 227 | tcc-based | 1 |
| 228 | tenuiflora-like | 1 |
| 229 | tetrahydroquinoline-derived | 1 |
| 230 | thermodilution-based | 1 |
| 231 | thromboembolism-related | 5 |
| 232 | tissue-obscuring | 1 |
| 233 | tissue-tracking | 4 |
| 234 | tnfr1-mediated | 1 |
| 235 | tnfr1-tnfr-associated | 1 |
| 236 | tradd-fas-associated | 1 |
| 237 | trandolopril | 1 |
| 238 | treatment-attributed | 1 |
| 239 | treatment-exacerbated | 2 |
| 240 | triptan-induced | 1 |
| 241 | ttr-related | 3 |
| 242 | vaccine-generated | 1 |
| 243 | val-mediated | 1 |
| 244 | vegfr-targeting | 1 |
| 245 | ventricular-arrhythmia-induced | 1 |
| 246 | vinorelbine-related | 2 |
| 247 | vk4s | 1 |
| 248 | world-isolating | 1 |
| 249 | yokukansan-induced | 1 |
| 250 | β-ar-induced | 1 |
| 1 | hplc-dad-ms. | 1 |
| 2 | anti-acne/ | 1 |
| 3 | antidepressant/ | 1 |
| 4 | -200±30 | 1 |
| 5 | 10850 | 2 |
| 6 | 6,390 | 1 |
| 7 | 1,192,082 | 1 |
| 8 | dca+nutlin-3 | 1 |
| 9 | 6.5-20.5 | 1 |
| 10 | 52-105 | 1 |
| 11 | p416 | 1 |
| 12 | 6.6±0.7 | 1 |
| 13 | non-trauma | 8 |
| 14 | nectariana | 1 |
| 15 | 1extra | 1 |
| 16 | events-cardiac | 1 |
| 17 | 99mtc-rbc | 2 |
| 18 | cbt/cc | 1 |
| 19 | hydrophilic/hydrophobic | 1 |
| 20 | dmba-specific | 1 |
| 21 | response-specific | 1 |
| 22 | skill-specific | 1 |
| 23 | mediator-specific | 6 |
| 24 | 'autophagic | 1 |
| 25 | sytemic | 1 |
| 26 | non-arrhythmic | 13 |
| 27 | nonarrhythmic | 27 |
| 28 | fetal/embryonic | 1 |
| 29 | diandric | 1 |
| 30 | necroptotic | 1 |
| 31 | accidental/bad | 1 |
| 32 | icd-lead | 1 |
| 33 | five-bed | 1 |
| 34 | ho-1-induced | 1 |
| 35 | ventricular-arrhythmia-induced | 1 |
| 36 | asphyxia-induced | 2 |
| 37 | tab-induced | 2 |
| 38 | aac-induced | 4 |
| 39 | cme-induced | 2 |
| 40 | yokukansan-induced | 1 |
| 41 | triptan-induced | 1 |
| 42 | kcn-induced | 2 |
| 43 | 7-hydroxy-3,4-dihydrocadalin-induced | 1 |
| 44 | i-r-induced | 1 |
| 45 | β-ar-induced | 1 |
| 46 | shs-induced | 1 |
| 47 | cps-induced | 2 |
| 48 | abt-induced | 1 |
| 49 | mlt-induced | 1 |
| 50 | fura-2am-loaded | 1 |
| 51 | advoided | 1 |
| 52 | multiple-cause-coded | 1 |
| 53 | scn5a-encoded | 1 |
| 54 | score-identified | 1 |
| 55 | dispatcher-identified | 1 |
| 56 | sympathetic-linked | 2 |
| 57 | parasympathetic-linked | 1 |
| 58 | 1/programmed | 1 |
| 59 | antiprogrammed | 1 |
| 60 | cardiovascular/unexplained | 2 |
| 61 | smear-defined | 1 |
| 62 | resveratrol-inspired | 1 |
| 63 | bone-anchored | 21 |
| 64 | tcc-based | 1 |
| 65 | edbd-based | 1 |
| 66 | percentile-based | 3 |
| 67 | tacrine-based | 1 |
| 68 | semaphorin-based | 1 |
| 69 | thermodilution-based | 1 |
| 70 | apoptosis-based | 1 |
| 71 | religious-based | 1 |
| 72 | dft-caused | 1 |
| 73 | continuously-superfused | 1 |
| 74 | treatment-exacerbated | 2 |
| 75 | prognosis-validated | 1 |
| 76 | cerl2-associated | 1 |
| 77 | bd-associated | 1 |
| 78 | dmd-associated | 1 |
| 79 | anthracycline-associated | 1 |
| 80 | arf-associated | 1 |
| 81 | rv-dilation-associated | 1 |
| 82 | tnfr1-tnfr-associated | 1 |
| 83 | post-ir-associated | 1 |
| 84 | fas-associated | 11 |
| 85 | tradd-fas-associated | 1 |
| 86 | fingerprint-associated | 1 |
| 87 | tnfr1-mediated | 1 |
| 88 | ccr2-mediated | 1 |
| 89 | mln4924-mediated | 1 |
| 90 | grb-mediated | 1 |
| 91 | dmc-mediated | 1 |
| 92 | macrolide-mediated | 1 |
| 93 | krg-mediated | 1 |
| 94 | val-mediated | 1 |
| 95 | mechanism-mediated | 3 |
| 96 | doxorubicin-mediated | 1 |
| 97 | deguelin-mediated | 1 |
| 98 | shoseiryuto-mediated | 1 |
| 99 | cr-mediated | 1 |
| 100 | lymphoma-related | 1 |
| 101 | melanoma-related | 8 |
| 102 | hypomagnesemic-related | 1 |
| 103 | pc-related | 4 |
| 104 | non-lead-related | 1 |
| 105 | vinorelbine-related | 2 |
| 106 | doxorubicin-dose-related | 1 |
| 107 | thromboembolism-related | 5 |
| 108 | enzastaurin-related | 1 |
| 109 | progression-related | 8 |
| 110 | gastric-cancer-related | 2 |
| 111 | ttr-related | 3 |
| 112 | hd-pbsct-related | 1 |
| 113 | sht-related | 2 |
| 114 | chemoradiotherapy-related | 1 |
| 115 | glutathiolated | 2 |
| 116 | manikin-simulated | 3 |
| 117 | dobutamine-stimulated | 2 |
| 118 | physician-designated | 1 |
| 119 | vaccine-generated | 1 |
| 120 | burn-generated | 2 |
| 121 | symbiotic-supplemented | 1 |
| 122 | physician-assisted | 5 |
| 123 | penk-adjusted | 1 |
| 124 | treatment-attributed | 1 |
| 125 | tetrahydroquinoline-derived | 1 |
| 126 | icg-derived | 1 |
| 127 | pchm-derived | 4 |
| 128 | saponin-permeabilized | 2 |
| 129 | non-steroid | 60 |
| 130 | nonsteroid | 34 |
| 131 | 5.5-month-old | 1 |
| 132 | pro-and | 6 |
| 133 | left-and | 1 |
| 134 | med-food | 1 |
| 135 | basal/standard | 1 |
| 136 | post-beta-blockade | 1 |
| 137 | tenuiflora-like | 1 |
| 138 | sic-like | 2 |
| 139 | perforationlike | 1 |
| 140 | all-stroke | 1 |
| 141 | iim-capable | 1 |
| 142 | nontreatable | 1 |
| 143 | bcl-xl-inhibitable | 1 |
| 144 | non-heritable | 4 |
| 145 | non-her2-gene | 3 |
| 146 | imidazo-pyridine | 1 |
| 147 | post-first-line | 3 |
| 148 | aminoquinoline-5,8-dione | 1 |
| 149 | safe-zone | 1 |
| 150 | ovary-type | 1 |
| 151 | pump-failure | 8 |
| 152 | bridging-exercise | 1 |
| 153 | resistance-because | 1 |
| 154 | serosfuse | 1 |
| 155 | bivariate/multivariate | 1 |
| 156 | best-value | 1 |
| 157 | cytokine-suppressive | 2 |
| 158 | perioerative | 1 |
| 159 | ish.perioperative | 1 |
| 160 | intra-/postoperative | 1 |
| 161 | intraoperative/postoperative | 2 |
| 162 | psycho-vegetative | 1 |
| 163 | post-preservative | 1 |
| 164 | b2-selective | 1 |
| 165 | anxioselective | 1 |
| 166 | sub-obstructive | 3 |
| 167 | death/mi/stroke/non-cabg | 1 |
| 168 | 10-kg | 3 |
| 169 | tissue-tracking | 4 |
| 170 | beam-hardening | 5 |
| 171 | nh2-containing | 1 |
| 172 | prebiotic-containing | 3 |
| 173 | gos-containing | 2 |
| 174 | 'lingering | 1 |
| 175 | beyond-bp-lowering | 1 |
| 176 | tissue-obscuring | 1 |
| 177 | cytokine-suppressing | 1 |
| 178 | cd107-expressing | 1 |
| 179 | world-isolating | 1 |
| 180 | non-terminating | 2 |
| 181 | fast-activating | 1 |
| 182 | non-rejecting | 1 |
| 183 | microtubule-targeting | 4 |
| 184 | vegfr-targeting | 1 |
| 185 | every-6-month | 1 |
| 186 | insights-both | 1 |
| 187 | nk92-mi | 1 |
| 188 | non-steroidal | 791 |
| 189 | analgesia/paracetamol/non-steroidal | 1 |
| 190 | nonsteroidal | 1,147 |
| 191 | non-nonsteroidal | 1 |
| 192 | aspirin/nonsteroidal | 2 |
| 193 | non-steriodal | 2 |
| 194 | nonsteriodal | 1 |
| 195 | sensorineuronal | 1 |
| 196 | hemilateral | 3 |
| 197 | centro-temporal | 1 |
| 198 | centrotemporal | 4 |
| 199 | restriction/fetal | 1 |
| 200 | out-of-hospital | 383 |
| 201 | studienhospital | 1 |
| 202 | trandolopril | 1 |
| 203 | apoptotic-cell | 2 |
| 204 | apoptosis-cell | 1 |
| 205 | post-spartum | 1 |
| 206 | regression-to-the-mean | 1 |
| 207 | controls-mean | 1 |
| 208 | acheulian | 1 |
| 209 | anglo-scandinavian | 44 |
| 210 | sudden | 2,852 |
| 211 | non-sudden | 15 |
| 212 | arrhythmic/sudden | 1 |
| 213 | nonsudden | 16 |
| 214 | pre-brain | 1 |
| 215 | 5=brain | 1 |
| 216 | noninsulin | 23 |
| 217 | double-spin | 1 |
| 218 | 33-week-gestation | 1 |
| 219 | double-polarization | 1 |
| 220 | 'exp | 1 |
| 221 | cardiovascolar | 1 |
| 222 | antireticular | 1 |
| 223 | cardiovascular/vascular | 1 |
| 224 | cardiomuscular | 1 |
| 225 | acellular/cellular | 1 |
| 226 | ovarian-cancer | 1 |
| 227 | infection/or | 1 |
| 228 | riskfor | 1 |
| 229 | pressure-sensor | 2 |
| 230 | vk4s | 1 |
| 231 | onassis | 1 |
| 232 | rutaceous | 1 |
| 233 | surreptitious | 10 |
| 234 | 6.3-t | 1 |
| 235 | preload-dependant | 1 |
| 236 | tak1-dependent | 1 |
| 237 | macrophage-dependent | 1 |
| 238 | pre-stent | 6 |
| 239 | preshunt | 3 |
| 240 | bak/bax | 1 |
| 241 | quad-frequency | 1 |
| 242 | goserelin/ovariectomy | 1 |
| 243 | post-septostomy | 1 |
| 244 | supra/infraclaviculary | 1 |
| 245 | smoking/injury | 1 |
| 246 | pre-angioplasty | 1 |
| 247 | endokeratoplasty | 1 |
| 248 | rats’ | 1 |
| 249 | perfusion™ | 1 |
| 250 | plr1-δ | 2 |